• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Eurazeo takes majority stake in NeoXam following ‘intense process’

  • Min Ho
  • 23 November 2022
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Eurazeo has taken a majority stake in financial services software provider NeoXam from backers Cathay Capital and Bpifrance, alongside founder Serge Delpla and its management team.

The firm is investing over EUR 100m in the Paris-headquartered business, which specialises in accounting, investment management and asset management software for the asset management and wider financial services industry, and generates around EUR 75m revenue, Pierre Meignen, managing director of the GP’s Small-Mid Buyout team, told Unquote.

Following what Meignen described as an “intense process” that saw a number of UK, US and French sponsors vying for the business, Eurazeo was able to clinch the deal after touting the GP’s international presence and growth track record for its companies.

Macquarie conducted the sale process marketing the business off around EUR 15m EBITDA, as reported by Unquote.

NeoXam is the sixth investment made by Eurazeo PME IV, which closed on EUR 1.07bn last July. The fund, which is double the size of Eurazeo PME III, will largely follow its predecessor in targeting French asset-light SMEs generating between EUR 10m to EUR 20m in EBITDA, as reported.

Around 45% of the fourth SME fund has been invested with two to three more years of deployment ahead, Meignen said.

Plans are now being drawn up by Eurazeo and the management to double NeoXam’s size through bolt-on acquisitions and organic growth over the next several years of holding period, he said.

A particular focus will be expanding its data management software capabilities, as well as growing the company internationally, including in Asia, the US and the UK, he added.

Company
NeoXam was created in 2014 following a carve-out from Sungard and a series of acquisitions. It has 550 employees, of which half are in R&D, across 15 offices worldwide, including in Europe, the US, Canada and Asia. The company provides “data-centric” solutions used by more than 120 clients, including asset managers, financial institutions, and global banks, to structure their IT systems. Its solutions cover front office (portfolio management system) to back and middle office, accounting (NAV) and regulatory and client reporting teams.

Advisors
Vendor – Macquarie

People
NeoXam - Serge Delpla (founder), Florent Fabre (managing director).
Eurazeo - Pierre Meignen (managing director of small-mid buyout team).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • France
  • Financials
  • Technology
  • Eurazeo
  • France

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013